Ridgeback Capital Investments L.P. 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:18 pm Sale |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Ridgeback Capital Investments L.P. | 1,100,000 4.200% |
-338,487 (-23.53%) |
Filing |
| 2020-12-23 4:01 pm Purchase |
2020-12-15 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Ridgeback Capital Investments L.P. | 1,438,487 5.400% |
1,438,487 (New Position) |
Filing |